Lifeboat Foundation

The MDI Biological Laboratory has announced new discoveries about the mechanisms underlying the regeneration of heart tissue by Assistant Professor Voot P. Yin, Ph.D., which raise hope that drugs can be identified to help the body grow muscle cells and remove scar tissue, important steps in the regeneration of heart tissue.

Heart disease is a leading cause of death in the western world. Yin is using zebrafish to study the regeneration of heart tissue because of the amazing capacity of these common aquarium fish to regenerate the form and function of almost any body part, including heart, bone, skin and blood vessels, regardless of their age. In contrast, the adult mammalian cardiovascular system has limited regenerative capacity.

“Although zebrafish look quite different from humans, they share an astonishing 70 percent of their genetic material with humans, including genes important for the formation of new heart muscle,” Yin said. “These genes are conserved in humans and other mammals, but their activity is regulated differently after an injury like a heart attack.”

Continue reading “Scientist identifies mechanism to regenerate heart tissue” »

More news from DARPA’s Electrical Rx efforts along with GSK’s own advancement.

In the future, doctors won’t treat diseases with drugs. Instead, they’ll use tiny implantable devices that communicate with our body’s electrical language.

Allen Institute working with Baylor on reconstructing neuronal connections.

The Intelligence Advanced Research Projects Activity (IARPA) has awarded an $18.7 million contract to the Allen Institute for Brain Science, as part of a larger project with Baylor College of Medicine and Princeton University, to create the largest ever roadmap to understand how the function of networks in the brain’s cortex relates to the underlying connections of its individual neurons.

The project is part of the Machine Intelligence from Cortical Networks (MICrONS) program, which seeks to revolutionize machine learning by reverse-engineering the algorithms of the brain.

Continue reading “IARPA awards $18.7 million contract to Allen Institute to reconstruct neuronal connections” »

Another data scientist with pragmatic thinking which is badly needed today. Keeping it real with Una-May O’Reilly.

Mumbai: Una-May O’Reilly, principal research scientist at Anyscale Learning For All (ALFA) group at the Massachusetts Institute of Technology Computer Science and Artificial Intelligence Laboratory, has expertise in scalable machine learning, evolutionary algorithms, and frameworks for large-scale, automated knowledge mining, prediction and analytics. O’Reilly is one of the keynote speakers at the two-day EmTech India 2016 event, to be held in New Delhi on 18 March.

In an email interview, she spoke, among other things, about how machine learning underpins data-driven artificial intelligence (AI), giving the ability to predict complex events from predictive cues within streams of data. Edited excerpts:

Continue reading “Machine learning underpins data-driven AI: Una-May O’Reilly” »

New to 3D-bioprinting: Blood vessels. http://voc.tv/14JQHoo

Cataracts can be cured by regrowing the lens in the eye using stem cells, a breakthrough hailed as ‘remarkable’ by scientists.

https://youtube.com/watch?v=Rw1odkI0Nw8

Stem cell breakthrough grows new cornea material that restores some sight to blind rabbits in an experiment.

Modifying animals to improve food quality consumption.

Birds and bees are just the beginning for a burgeoning technology.

Wearables and other connected devices have been available to help treat chronic conditions like asthma and heart disease for a while now. But thus far, the nation’s 30 million diabetics haven’t seen much to help them improve their health or reduce the daily grind of finger pricks and needle pokes.

The $2.5 billion connected-care industry may be off to a late start in diabetes, but it’s making up for lost time. A new breed of connected glucometers, insulin pumps and smartphone apps is hitting the market. They promise to make it easier for diabetics to manage the slow-progressing disease and keep them motivated with feedback and support. In as little as two years, the industry plans to take charge of the entire uncomfortable, time-consuming routine of checking and regulating blood-sugar levels with something called an artificial pancreas. Such systems mimic the functions of a healthy pancreas by blending continuous glucose monitoring, remote-controlled insulin pumps and artificial intelligence to maintain healthy blood-sugar levels automatically.

For Jeroen Tas, CEO of Philips’ Connected Care and Health Informatics unit, diabetes management is also personal: his daughter Kim is diabetic.

Continue reading “‘Artificial pancreas’ is one of new tech devices aimed at diabetes” »